A Study of the Cost for Patients Operated for Adhesive Obstruction (SBO) During a Five-year Period
NCT ID: NCT03602352
Last Updated: 2018-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
402 participants
OBSERVATIONAL
2015-01-01
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Band Adhesions in Relation to Previous Abdominal Surgery
NCT03663023
Evaluation of the Peel Force of New Adhesives From the Skin
NCT03200444
Conservative Versus Operative Management in Adhesive Intestinal Obstruction
NCT06870864
Textbook Outcomes in Urgent Appendectomy
NCT06765044
Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions
NCT00512356
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The costs for hospital stay, radiology, Intensive Care Unit (ICU)-care, operation for the index SBO care event were calculated. The cost for revisit, sick leave and recurrent SBO during follow-up were calculated. Patients were followed to 31st January 2017, last medical note or death.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgery for adhesive surgical bowel obstruction (SBO)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Urban Karlbom, MD PhD
Role: STUDY_CHAIR
Region Uppsala
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASBO-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.